Key result
Senescent endothelial cells are highly susceptible to SARS-CoV-2 infection, which alters the expression of genes involved in blood coagulation and inflammation more severely than in early passage cells.
Why the study?
COVID-19 is characterized by striking high mortality in the elderly, but the mechanistic insights remain unclear.
Senescent endothelial cells are highly susceptible to SARS-CoV-2 infection, leading to enhanced expression of inflammation and coagulation genes, which may explain the severe microangiopathy and thrombosis seen in elderly COVID-19 patients.
Senescent ECs may heighten elderly COVID-19 risk; leaves open senescence-targeted interventions pending clinical validation.
The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains to spread worldwide. COVID-19 is characterized by the striking high mortality in elderly; however, its mechanistic insights remain unclear. Systemic thrombosis has been highlighted in the pathogenesis of COVID-19, and lung microangiopathy in association with endothelial cells (ECs) injury has been reported by post-mortem analysis of the lungs. Here, we experimentally investigated the SARS-CoV-2 infection in cultured human ECs, and performed a comparative analysis for post-infection molecular events using early passage and replicative senescent ECs. We found that; (1) SARS-CoV-2 infects ECs but does not replicate and disappears in 72 hours without causing severe cell damage, (2) Senescent ECs are highly susceptible to SARS-CoV-2 infection, (3) SARS-CoV-2 infection alters various genes expression, which could cause EC dysfunctions, (4) More genes expression is affected in senescent ECs by SARS-CoV-2 infection than in early passage ECs, which might causes further exacerbated dysfunction in senescent ECs. These data suggest that sustained EC dysfunctions due to SARS-CoV-2 infection may contribute to the microangiopathy in the lungs, leading to deteriorated inflammation and thrombosis in COVID-19. Our data also suggest a possible causative role of EC senescence in the aggravated disease in elder COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Urata et al. (2022) studied COVID-19 associated endothelial dysfunction. SARS-CoV-2 infection vs. Early passage HUVECs or uninfected cells was evaluated on SARS-CoV-2 RNA expression and viral entry. Senescent endothelial cells are highly susceptible to SARS-CoV-2 infection, which alters the expression of genes involved in blood coagulation and inflammation more severely than in early passage cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: